November 2, 2020
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding the Drug Enforcement Administration’s (DEA) proposed rule on suspicious orders.
“HDA is encouraged that DEA is taking steps to provide further direction around the monitoring and reporting of suspicious orders. The Alliance and its distributor members have long sought formal guidance from the Agency on suspicious orders reporting, without which, individual companies have been left to develop their own unique programs. HDA looks forward to engaging with the DEA as this proposal goes through the rulemaking process to support greater communication and coordination with federal and state regulators and our supply chain partners — and ultimately, enhance our collective response to this public health crisis.”